Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments

The diagnosis of neurodegenerative diseases (NDDs) represents an increasing social burden, with the unsolved issue of disease-modifying therapies (DMTs). The failure of clinical trials treating Alzheimer′s Disease (AD) so far highlighted the need for a different approach in drug design and patient s...

Descripción completa

Detalles Bibliográficos
Autores principales: Giampietri, Linda, Belli, Elisabetta, Beatino, Maria Francesca, Giannoni, Sara, Palermo, Giovanni, Campese, Nicole, Tognoni, Gloria, Siciliano, Gabriele, Ceravolo, Roberto, De Luca, Ciro, Baldacci, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029739/
https://www.ncbi.nlm.nih.gov/pubmed/35453843
http://dx.doi.org/10.3390/diagnostics12040796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029739/
https://www.ncbi.nlm.nih.gov/pubmed/35453843
http://dx.doi.org/10.3390/diagnostics12040796

Ejemplares similares